Please login to the form below
arthritis
This page shows the latest arthritis news and features for those working in and with pharma, biotech and healthcare.
Pfizer to buy 8.1% stake in Valneva in support of joint Lyme disease programme
If left untreated, the disease can cause more serious complications including arthritis, carditis or affect the nervous system.
Latest news
-
Amgen’s Riabni combination granted FDA approval for rheumatoid arthritis
Rheumatoid arthritis is a long-term condition that causes painful swelling and stiffness in the joints. ... Amgen’s Riabni (rituximab-arrx), in combination with methotrexate, has been approved by the US Food and Drug Administration (FDA) for adults
-
Sandoz launches ‘Act4Biosimilars’ initiative to address global health inequalities
Biosimilars can be used as an alternative to biological drugs once the patents have expired and are used to treat a variety of diseases such as cancer, diabetes, arthritis and psoriasis.
-
Pfizer and Valneva announce positive phase 2 paediatric data for lyme disease vaccine
When left untreated, the disease can cause more serious complications like arthritis, carditis or affect the nervous system.
-
AbbVie’s Rinvoq accepted by SMC for atopic dermatitis
The SMC has now approved Rinvoq for the treatment of psoriatic arthritis, atopic dermatitis and rheumatoid arthritis for people living in Scotland.
-
Study provides new insights into Alzheimer's disease
Treatments that restrict TNF are already widely used to treat inflammatory diseases, including Crohn’s disease, rheumatoid arthritis and psoriasis.
More from news
Approximately 99 fully matching, plus 681 partially matching documents found.
Latest Intelligence
-
Alzheimer’s: the search for a cure
As early as the 1990s, data from several large epidemiological studies was published indicating that chronic anti-inflammatory treatments for patients with arthritis showed protective qualities against developing Alzheimer’s.
-
Setting up for success in a post-Brexit, post-pandemic Britain
and Rheumatoid Arthritis (RA). ... people with moderate as well as severe rheumatoid arthritis – aiming to avoid irreversible damage as early as possible.
-
Helping patients to help themselves – how pharma can get more from patient support programmes
For example, when developing a patient support programme for patients with Ankylosing Spondylitis and Psoriatic Arthritis, earthware identified that, for newly diagnosed patients, the impact of receiving the diagnosis on their
-
The US celebrates five years of biosimilars on the market – a look to the past, present and future
chronic diseases such as rheumatoid arthritis.
-
Innovation in a digital context is not about technology – it’s about people
We have also been continuously developing new content based on patients’ needs: an interactive treatment pathway, an interactive appointment-preparation video, ever-growing support for psoriatic arthritis, advice on treatments and
More from intelligence
Approximately 0 fully matching, plus 59 partially matching documents found.
Latest appointments
-
Aurora boosts team with new hires and internal promotions
Prior to joining Aurora in 2015, O’Farrell worked at the patient group Arthritis Ireland.
-
Portland Health appoints Jamie Hewitt as an account director
He joins the firm from the National Rheumatoid Arthritis Society, where he was its head of government affairs, leading the policy and public affairs functions. ... During his time at the National Rheumatoid Arthritis Society, Hewitt ran UK campaigns to
-
Liberation Unlimited promotes Vicky Smith
oncology, rheumatoid arthritis and eye health.
-
Galapagos appoints Bart Filius as chief financial officer
His vast experience in big pharma and his sharp strategic view will help us bring Galapagos to the next level, as we prepare to have our rheumatoid arthritis molecule GLPG0634 enter
-
TiGenix appoints Dr Marie Paule Richard
In her new role Richard will be responsible for the development of several products in Europe and the US, including rheumatoid arthritis and severe sepsis candidate Cx611 and Cx601, which is
More from appointments
Approximately 1 fully matching, plus 12 partially matching documents found.
Latest from PMHub
-
What does the future hold for clinical trial recruitment?
For example, new commonalities have been discovered between Type 1 diabetes, lupus, multiple sclerosis and rheumatoid arthritis, suggesting that drugs already in use to treat one autoimmune disease could be equally
-
Fishawack Health welcomes expert-led dermatology initiative FIDE to its group
About FIDE. FIDE is a full-service consultancy with extensive expertise in the pathophysiology, clinical presentation, and treatment of chronic inflammatory diseases, including psoriasis, psoriatic arthritis, atopic dermatitis, and hidradenitis
-
Clinical trial branding: 5 reasons it’s important to your clinical trials
Imagine the branding you’d use to target an audience for an arthritis clinical trial, how would that differ to the branding used for a depression clinical trial?
-
What you can do to help make invisible illnesses more visible?
This can include chronic physical conditions like arthritis and diabetes, or mental illnesses.
-
Covid-19: how is it affecting prescribing patterns?
Rheumatoid arthritis. Rheumatoid arthritis has seen a significant rise in prescribing rates for biosimilars. ... This is to be expected because as generic biologics get approved, use of branded biologics goes down and the arthritis pathway becomes
More from PMHub
Approximately 10 fully matching, plus 33 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Bristol Myers Squibb announces positive trial results for treatment of MS
- Biogen and Happify Health team up to create digital platform for MS patients
- Moderna to launch Innovation and Technology Center in the UK
- Enanta takes legal action against Pfizer over Paxlovid patent infringement
- Novartis and Precision BioSciences announce in vivo gene editing collaboration
- A creative awakening – how pharma is bringing innovation to the patient journey
- How Resonant’s innovation and creativity resolve healthcare communications challenges
- The pharma dichotomy
- Our Top 5 Pharma Picks From Cannes Lions
- Live Webinar: Streamlining the Drug Development Process to Transform Global Health
- Innovative Health Initiative launches first two calls for proposals to tackle ‘biggest’ health research challenges
- NHS App to revolutionise digital health and care with major digital updates by 2023
- ALL SYSTEMS GO: UNDERSTANDING WHO’S WHO IN THE NEW NHS LANDSCAPE
- AstraZeneca’s Evusheld phase 3 results show high level of protection against COVID-19
- College of Medicine launches Beyond Pills campaign to tackle overprescribing in UK health system
- Pfizer, Mylan move ahead with generics merger and spin-out
- Research from Imperial College London shows single brain scan could diagnose Alzheimer’s disease
- Roche shares new positive Ocrevus data for MS patients
PMHub
3 Monkeys Zeno
3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...
Latest intelligence
- Our Top 5 Pharma Picks From Cannes Lions
- Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
- The Evolving Role of the Sales Rep
- The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
- Measure your omnichannel maturity with our new tool
- Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
